FluoroPharma Medical, Inc. (FPMI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 29, 2026
FluoroPharma Medical Market Cap
FluoroPharma Medical has a market cap or net worth of $5.52 thousand as of November 10, 2026. It is the 52,090th most valuable company in the world and the 8,013th biggest in the United States. Its market cap has increased by 19,596.43% in one year.
Market Cap
5.52K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,013 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 17, 2011, FluoroPharma Medical's market cap has decreased from 24.55M to 5.52K, a decrease of -99.98%. That is a compound annual growth rate of -42.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 5.52K | 99.96% |
| Dec 23, 2024 | 2.76K | - |
| Dec 14, 2023 | 2.76K | -94.67% |
| Dec 27, 2022 | 51.74K | 152,064.71% |
| Dec 29, 2021 | 34.00 | -99.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| Better Therapeutics | 5.45K |
| LadRx | 5.45K |
| Aridis Pharmaceuticals | 5.33K |
| MultiCell Technologies | 5.00K |